Skip to main content
. 2023 Aug 18;13(8):954. doi: 10.3390/metabo13080954
AD Alzheimer’s disease
MetS Metabolic syndromes
DM Diabetes mellitus
T1DM Type 1 diabetes mellitus
T2DM Type 2 diabetes mellitus
10-HDA 10-Hydroxy-2-decenoic acid
RJ Royal Jelly
ER Endoplasmic reticulum
IR Insulin resistance
MCI Mild cognitive impairment
GLP-1R Glucagon-like peptide-1 receptor
PPARs Peroxisome proliferator-activated receptors
GSK-3 Glycogen synthase kinase-3
TREM2 Triggering receptor expressed on myeloid cells 2
BMI Body mass index
BBB Blood–brain barrier
AGEs Advanced glycation end products
RMSD Root mean square deviation